Apozeal Pharmaceuticals Inc.

APOZEAL is a pharmaceutical company with a vision to serve our patients with high quality medicines at affordable price. Company is founded by 2 pharmaceutical executives with over 60 years of experience in pharmaceutical marketing, sales, distribution, research & development, commercial operations and general management. Apozeal Pharma owns 10 FDA approved ANDA products for US market, many ANDAs filed with FDA waiting for approval and many more in development.

Our Mission

At Apozeal we are firmly committed to transforming patients lives by providing medications at lower, affordable price that are manufactured with uncompromising quality, integrity, compliance and ethics.

Our Vision

At Apozeal Pharmaceuticals, we promote diversity in the workplace, we care for our employees who work tirelessly towards our vision, we care for the vendors and customers that have become an integral part of the our family, we care for the health of the patients who continuously rely on the Quality of our products.

WHO WE ARE

Founded 2023
2091 Hartel St.
Levittown PA 19057
75,000 Sqft Facilities

BUSINESS DEVELOPMENT

Product Development, Contract Manufacturing, Contract Packaging, Analytical Testing, Licensing

CAPABILITIES

Oral liquid solution and suspension and suppository manufacturing capability from small to large commercial scale.

Our Facility

Facility is fully equipped with dispensing, cGMP manufacturing lines, primary and secondary packaging lines with serialization capabilities and warehouse and distribution.

View Facility

Our Services

Research and Development

Apozeal Pharmaceuticals has a state of the art research and development laboratory with various capabilities from bench level development to scale up.

Analytical

Our analytical facility is fully equipped with state of the art analytical instruments such as GC, HPLC for raw material,in-process and finished product testing inhouse. We deliver quality driven most reliable and consistent data.

Manufacturing

Apozeal has small mid to large commercial scale oral liquid solutions and suspension manufacturing and packaging capabilites. Apozeal has high speed commercial suppository manufacturing & packaging lines. Suppository equipments from small, medium and commercial scale are available.

Consultation For Pharmaceutical Development

We are available to small, mid size, large Biopharma / Pharmaceutical organizations for consultation on various strategies to expedite Pharma development & develop phase appropriate robust drug product formulations and processes.

Packaging

Our Packaging Process involves all of the operations from production through drug distribution channels to the end consumer.

CDMO

Apozeal Pharmaceuticals offers services in contract development for a variety of dosage forms as well as complex niche
formulations.

Company News

Apozeal Pharma, based in Levittown. P.A. 19057 is pleased to announce the launch of the first product Hydroxyzine HCL Solution, USP 10mg/5ml to U.S Market. Hydroxyzine HCL Solution, USP 10mg/5ml is US FDA approved and marketed in bottles of 1 Pint (473 mL). The drug product is indicated for the treatment of symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. It is useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritic. It is also used as sedative in certain circumstances. Apozeal is manufacturing the drug product at its Levittown PA facility in the US.

Apozeal Pharma will be launching 9 additional FDA approved products in its portfolio in the near future from its Levittown, PA facility. Apozeal also has plans to diversify to other pharmaceutical dosage forms, i.e. solid orals, injectables, biologics in the future.